APA

Than N. N., Hodson J., Schmidt-Martin D., Taubert R., Wawman R. E., Botter M., Gautam N., Bock K., Jones R., Appanna G. D., Godkin A., Montano-Loza A. J., Lammert F., Schramm C., Manns M. P., Swain M., Burak K. W., Adams D. H., Hirschfield G. M. & Oo Y. H. (2019). Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. : JHEP reports : innovation in hepatology.

Chicago

Than Nwe Ni, Hodson James, Schmidt-Martin Daniel, Taubert Richard, Wawman Rebecca E, Botter Meemee, Gautam Nishant, Bock Kilian, Jones Rebecca, Appanna Gautham D, Godkin Andrew, Montano-Loza Aldo J, Lammert Frank, Schramm Christoph, Manns Michael P, Swain Mark, Burak Kelly W, Adams David H, Hirschfield Gideon M and Oo Ye Htun. 2019. Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. : JHEP reports : innovation in hepatology.

Harvard

Than N. N., Hodson J., Schmidt-Martin D., Taubert R., Wawman R. E., Botter M., Gautam N., Bock K., Jones R., Appanna G. D., Godkin A., Montano-Loza A. J., Lammert F., Schramm C., Manns M. P., Swain M., Burak K. W., Adams D. H., Hirschfield G. M. and Oo Y. H. (2019). Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. : JHEP reports : innovation in hepatology.

MLA

Than Nwe Ni, Hodson James, Schmidt-Martin Daniel, Taubert Richard, Wawman Rebecca E, Botter Meemee, Gautam Nishant, Bock Kilian, Jones Rebecca, Appanna Gautham D, Godkin Andrew, Montano-Loza Aldo J, Lammert Frank, Schramm Christoph, Manns Michael P, Swain Mark, Burak Kelly W, Adams David H, Hirschfield Gideon M and Oo Ye Htun. Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. : JHEP reports : innovation in hepatology. 2019.